Paradigm Biopharmaceuticals | PAR - Current Liabilities

Stock Price
0.32
Daily Change
0.02 6.78%
Monthly
-14.86%
Yearly
-43.24%
Q1 Forecast
0.30

Paradigm Biopharmaceuticals reported AUD3.23M in Current Liabilities for its fiscal semester ending in June of 2025.





Current Liabilities Change Date
Avita Medical AUD 62.6M 42.44M Jun/2025
Medical Developments International AUD 7.82M 1.45M Jun/2025
Neuren Pharmaceuticals AUD 7.92M 37.84M Jun/2025
Pacific Edge NZD 7.22M 2.54M Dec/2025
PYC Therapeutics AUD 12.32M 939.58K Jun/2025
Telix Pharmaceuticals AUD 330.91M 72.54M Dec/2024